SCHEDULE 13D/A: PineBridge Funds Drastically Reduce Stake in IBEX Ltd, Fall Below 5% Ownership Threshold
Beneficial Ownership Change
PineBridge Global Emerging Markets Partners II, L.P. and its affiliates have significantly reduced their beneficial ownership in IBEX Ltd, falling below the 5% reporting threshold as of February 26, 2025.
Summary
- PineBridge Global Emerging Markets Partners II, L.P. (GEM II) and related entities have filed an Amendment No. 7 to their Schedule 13D, indicating a significant reduction in their beneficial ownership of IBEX Ltd Common Shares.
- As of February 26, 2025, the Reporting Persons beneficially own 508,436 Common Shares, representing 3.9% of the outstanding shares.
- This percentage is calculated based on 13,191,924 Common Shares outstanding as of January 31, 2025, as reported in IBEX Ltd's quarterly report on Form 10-Q.
- The Reporting Persons ceased to beneficially own more than 5% of IBEX Ltd's outstanding Common Shares as of February 26, 2025.
- Between February 20, 2025, and February 26, 2025, GEM II sold a total of 590,547 Common Shares in open market transactions.
- Specific sales include 3,218 shares at a weighted average price of $26.2789 on February 20, 2025; 9,751 shares at $25.7609 on February 21, 2025; 72,145 shares at $25.7523 on February 24, 2025; 196,066 shares at $25.8013 on February 25, 2025; and 309,367 shares at $25.8131 on February 26, 2025.
Sentiment
Score: 3
Explanation: The sentiment is negative as a significant institutional investor has substantially reduced its stake in the company, indicating a potential lack of confidence or strategic divestment.
Negatives
- A significant institutional investor, PineBridge Global Emerging Markets Partners II, L.P., has reduced its stake in IBEX Ltd, falling below the 5% beneficial ownership threshold.
- The divestment of 590,547 shares over a short period (February 20-26, 2025) could signal a lack of confidence or a strategic exit by the reporting entity.
Risks
- The reduction in beneficial ownership by a major institutional investor could negatively impact investor sentiment and potentially lead to downward pressure on the stock price.
Future Outlook
The document does not provide any forward-looking statements or guidance from IBEX Ltd or the reporting persons regarding the company's future operations or financial performance.
Industry Context
This filing is a routine disclosure of a change in beneficial ownership by an institutional investor and does not provide specific information to analyze broader industry trends or competitive landscape for IBEX Ltd.
Stakeholder Impact
- Shareholders: May experience negative sentiment and potential downward pressure on share price due to a large institutional investor reducing its stake.
Key Dates
| Date | Description |
|---|---|
| 2022-01-05 | Initial Schedule 13D filed with the SEC. |
| 2023-07-13 | Amendment to Form 3 filed by GEM II, GEM II GP, Mr. Mellinger and Mr. Clowe, attaching Power of Attorney. |
| 2024-09-17 | Amendment No. 1 to Schedule 13D filed with the SEC. |
| 2024-10-04 | Amendment No. 2 to Schedule 13D filed with the SEC. |
| 2024-11-22 | Amendment No. 3 to Schedule 13D filed with the SEC. |
| 2024-12-06 | Amendment No. 4 to Schedule 13D filed with the SEC. |
| 2025-01-07 | Amendment No. 5 to Schedule 13D filed with the SEC. |
| 2025-01-31 | Date as of which IBEX Ltd reported 13,191,924 Common Shares outstanding in its Form 10-Q. |
| 2025-02-06 | IBEX Ltd's quarterly report on Form 10-Q filed with the SEC. |
| 2025-02-14 | Amendment No. 6 to Schedule 13D filed with the SEC. |
| 2025-02-20 | Date of first reported share sale by GEM II (3,218 shares at $26.2789). |
| 2025-02-21 | Date of share sale by GEM II (9,751 shares at $25.7609). |
| 2025-02-24 | Date of share sale by GEM II (72,145 shares at $25.7523). |
| 2025-02-25 | Date of share sale by GEM II (196,066 shares at $25.8013) and the event date requiring this filing. |
| 2025-02-26 | Date of last reported share sale by GEM II (309,367 shares at $25.8131) and the date Reporting Persons ceased to beneficially own more than 5%. |
| 2025-02-27 | Date of signing of Amendment No. 7 to Schedule 13D. |
Recommendation
sellKeywords
IBEX Ltd, Schedule 13D, Beneficial Ownership, Share Sale, Institutional Investor, PineBridge Global Emerging Markets Partners II, SEC Filing, Common Shares, Divestment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.